Two of the best-selling drugs in the US are Procrit from Johnson & Johnson (NYSE: JNJ) and Aranesp from Amgen (NASDAQ:AMGN). The products treat anemia in patients with kidney dialysis issues. Studies…
According to Reuters, weak confidence and rising prices are fuelin stagflation fears. Reuters writes that the long fight between Microsoft (MSFT) and Yahoo! (YHOO) over a takeover will help Google (GOOG).’ Reuters…
These are the new combined holdings (alphabetically H-P) from Warren Buffett’s Berkshire Hathaway (NYSE: BRK-A) for the period ended December 31, 2007: Home Depot (NYSE: HD) 4.181 million shares for $112.6 million.…
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. This…
Below is a list of Dow Jones Industrial Average components that are actually down the least on an ugly day. There has been news on most of these or if not there…
Johnson & Johnson (JNJ) announced record sales of $16.0 billion for the fourth quarter of 2007, an increase of 16.6% as compared to the fourth quarter of 2006. Net earnings and diluted…
Douglas A. McIntyre Of the earnings that will hit over the next week, none are as important as Microsoft (MSFT) and AT&T (T). Both have broad business which touch consumers and businesses worldwide. Both carry…
Monday is a market holiday in observance of Martin Luther King Day in the U.S. But after that we have an earnings deluge with hundreds of companies issuing their earnings. For the…
These are not the only top analyst calls impacting share prices this morning, but these are the main calls that 247WallSt.com is focusing on in pre-market trading this Friday morning: Allstate (ALL)…
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since lists need continual updating. Our originally updated list of tier one defensive…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had…
According to Reuters, OPEC will probably keep oil output at current levels. Reuters writes that a goverment plan to help sub-prime borrowers will probably freeze their rates for five years. Reuters writes…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness in the stent market. Stranger than fiction. According to MarketWatch, Abbott says…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX) and Johnson & Johnson (JNJ). Stents are small mess implants which are…
